LevelJump Announces Grant of Stock Options

Rhea-AI Summary

LevelJump Healthcare Corp (OTC: JMPHF) granted 2,250,000 incentive stock options to three directors under its 2022 Equity Incentive Plan. Each option allows purchase of one common share at an exercise price of $0.065 until February 24, 2031. There are no vesting restrictions.

Positive

• 2,250,000 options granted to three directors under the 2022 Equity Incentive Plan
• Low exercise price of $0.065 per common share for option holders

Negative

• No vesting restrictions allow immediate exercisability, increasing potential near-term dilution
• Options expire Feb 24, 2031, creating a long window for conversion and dilution

Toronto, Ontario--(Newsfile Corp. - February 26, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("Leveljump" or the "Company") announces that, pursuant to the Company's 2022 Equity Incentive Plan, it has granted an aggregate of 2,250,000 incentive stock options (the "Options") to three directors of the Company. Each Option entitles the optionee to acquire one common share of the Company at an exercise price of $0.065 per common share until February 24, 2031. There are no vesting restrictions.

About LevelJump Healthcare

LevelJump Healthcare Corp. (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its Diagnostic Centres. JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.

ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.

Mitchell Geisler
Chief Executive Officer
info@leveljumphealthcare.com
647-340-2020

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release, and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/285414

FAQ

What stock option grant did LevelJump (JMPHF) announce on February 26, 2026?

The company granted 2,250,000 incentive stock options to three directors. According to the company, each option is exercisable at $0.065 per share until Feb 24, 2031 with no vesting restrictions.

How could the 2,250,000 options affect JMPHF shareholders?

The options create potential dilution if exercised, increasing outstanding shares. According to the company, the grants are exercisable at $0.065 and have no vesting restrictions, enabling immediate conversion risk for shareholders.

Who received the stock options in LevelJump's February 26, 2026 grant?

Three directors of LevelJump received the stock options. According to the company, the aggregate grant was 2,250,000 options under the 2022 Equity Incentive Plan, each exercisable at $0.065.

What are the exercise price and expiry date for LevelJump's granted options (JMPHF)?

Each option has an exercise price of $0.065 and expires on February 24, 2031. According to the company, there are no vesting restrictions attached to these options.

Are there vesting restrictions on the LevelJump option grants announced February 26, 2026?

No, there are no vesting restrictions on the granted options. According to the company, the 2,250,000 options are fully exercisable immediately at $0.065 per share until Feb 24, 2031.